Insiders · Profile

Lewis Michael E

Chief Scientific Advisor at Tvardi Therapeutics. Filing since 2 Feb 2015. CIK 0001297065

Company
Date
Role
Action
Shares
Amount
Of holding
26 Jan 2016
Chief Scientific Advisor
Sold, plan not stated
7,262
$79.37K
2.3%
1 Jul 2015
Chief Scientific Advisor
Sold, plan not stated
7,262
$84.67K
2.2%
1 Jun 2015
Chief Scientific Advisor
Sold, plan not stated
7,262
$68.99K
2.2%
1 May 2015
Chief Scientific Advisor
Sold, plan not stated
7,262
$77.27K
2.1%
1 Apr 2015
Chief Scientific Advisor
Sold, plan not stated
7,262
$71.89K
2.1%
2 Mar 2015
Chief Scientific Advisor
Sold, plan not stated
7,262
$73.42K
2.0%
2 Feb 2015
Chief Scientific Advisor
Sold, plan not stated
7,262
$76.98K
2.0%
7 decisions on file.